Figure 4.

Seroprevalence of antihepatitis E virus (HEV) IgG by Acute Liver Failure Study Group (ALFSG) site and region. There were 21 sites in the ALFSG who contributed cases to the study between 2008 and 2018. One of the 10 cases from Canada had detectable anti-HEV IgG (data not shown). *Represent states with an ALFSG clinical site.